Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Boston Scientific reports similar Taxus outcomes in men and women

Interventional device developer Boston Scientific released results fromits Taxus Woman study, which found that paclitaxel-eluting stents havesimilar clinical outcomes in women and men, despite the higher riskprofile in female patients.

New guidelines on stress echocardiography released

The Journal of the American Society of Echocardiography todayreleased new recommendations to further support the role of stressechocardiography in accurately identifying coronary artery disease andin determining prognosis of patients with known or suspected coronaryartery disease.

Boston Scientific releases Taxus stent trial results

Interventional device developer Boston Scientific released the finalized five-year results from its Taxus II clinical trial.

Siemens makes new product introductions

Siemens Medical Solutions has introduced a new portable ultrasounddevice, the Acuson P10, intended for complementary initial diagnosticcare and triage, particularly in cardiology, emergency care andobstetrics. In addition, Siemens has showcased new cardiac offerings atthe 2007 Congress of the European Society of Cardiology this week inVienna, Austria.

Agfa adds to Impax Cardiovascular capabilities

Agfa HealthCare introduced new capabilities for its ImpaxCardiovascular Suite at the European Society of Cardiology Congress2007 in Vienna, Austria, this week.

CardioDynamics completes Vermed sale

Impedance cardiography device developer CardioDynamics reported that ithas completed the sale of its Vermed unit to Medical Device Partners, aVermont corporation recently organized by Vermed's management team, fora cash purchase price of $8 million.

Boston Scientific settles with state attorneys general

Three subsidiaries of Boston Scientific—Guidant Corporation, CardiacPacemakers and Guidant Sales—which are known as Boston ScientificCardiac Rhythm Management, have reached an agreement with the attorneysgeneral of 35 states and the District of Columbia to settleinvestigations associated with Guidant Corporation's Ventak Prizm 2DRModel 1861, Contak Renewal Model H135 and Contak Renewal 2 Model H155devices.

Australian Cardiology PACS market growth tied to workflow needs

The adoption of Cardiology PACS in Australia is expected to grow at acompound annual growth rate of 14.5 percent through 2010 and is beingdriven by the need to make cardiology workflow more patient-centric andefficient in that country, according to analysis by market researchfirm Frost & Sullivan.

Displaying 1585 - 1592 of 1765

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup